Pre-operative Nivolumab and Ipilimumab, Followed by Post-operative Nivolumab, for MSI/dMMR Oeso-gastric Adenocarcinoma.

Clinical trial NCT04006262 · ACTIVE_NOT_RECRUITING

Trial details

NCT number: NCT04006262
Sponsor: GERCOR - Multidisciplinary Oncology Cooperative Group
Status: ACTIVE_NOT_RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Localized Oesogastric Adenocarcimona MSI and or dMMR

Start date: 2019-10-23
Primary completion: 2025-10-01
Enrollment: 32

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.